Evidence that locus coeruleus is the site where clonidine and drugs acting at alpha 1- and alpha 2-adrenoceptors affect sleep and arousal mechanisms
The behavioural and electrocortical (ECoG) effects of clonidine were studied after microinjection into the third cerebral ventricle, or microinfusion into some specific areas of the rat brain rich in noradrenaline-containing cell bodies (locus coeruleus) or into areas receiving noradrenergic termina...
Saved in:
Published in | British journal of pharmacology Vol. 90; no. 4; pp. 675 - 685 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.04.1987
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The behavioural and electrocortical (ECoG) effects of clonidine were studied after microinjection into the third cerebral ventricle, or microinfusion into some specific areas of the rat brain rich in noradrenaline-containing cell bodies (locus coeruleus) or into areas receiving noradrenergic terminals (dorsal hippocampus, amygdaloid complex, thalamus, frontal and sensimotor cortex). The ECoG effects were continuously analysed and quantified by means of a Berg-Fourier analyser as total power and as power in preselected bands of frequency. Clonidine (9.4 to 75 nmol) given into the third cerebral ventricle produced behavioural sedation and sleep and a dose-dependent increase in ECoG total voltage power as well as in the lower frequency bands. Much lower doses were required to produce similar behavioural and ECoG spectrum power effects after either unilateral or bilateral microinfusion of clonidine into the locus coeruleus. Doses of clonidine equimolar to those given into the third cerebral ventricle, were almost ineffective in inducing behavioural and ECoG sleep after their microinfusion into the dorsal hippocampus. In addition, a dose (0.56 nmol) of clonidine which, given into the locus coeruleus, produced marked behavioural sleep and ECoG synchronization, lacked effects when given into the ventral or anterior thalamus, into the amygdaloid complex or onto the frontal and sensimotor cortex. The behavioural and ECoG spectrum power effects of clonidine given into the third cerebral ventricle or into the locus coeruleus were prevented by antagonists of alpha 2-adrenoceptors but not by alpha 1-adrenoceptor antagonists. Intraventricular microinjection, or microinfusion into the locus coeruleus, of yohimbine, a selective alpha 2-adrenoceptor antagonist, produced behavioural arousal, increase in locomotor and exploratory activity, tachypnoea and ECoG desynchronization with a significant reduction in total voltage power. Similar stimulatory effects were also observed after microinjection of phentolamine into the same sites. No significant effects on behaviour and ECoG activity were evoked after intraventricular injection or microinfusion into the locus coeruleus of prazosin or methoxamine. |
---|---|
AbstractList | The behavioural and electrocortical (ECoG) effects of clonidine were studied after microinjection into the third cerebral ventricle, or microinfusion into some specific areas of the rat brain rich in noradrenaline-containing cell bodies (locus coeruleus) or into areas receiving noradrenergic terminals (dorsal hippocampus, amygdaloid complex, thalamus, frontal and sensimotor cortex). The ECoG effects were continuously analysed and quantified by means of a Berg-Fourier analyser as total power and as power in preselected bands of frequency. Clonidine (9.4 to 75 nmol) given into the third cerebral ventricle produced behavioural sedation and sleep and a dose-dependent increase in ECoG total voltage power as well as in the lower frequency bands. Much lower doses were required to produce similar behavioural and ECoG spectrum power effects after either unilateral or bilateral microinfusion of clonidine into the locus coeruleus. Doses of clonidine equimolar to those given into the third cerebral ventricle, were almost ineffective in inducing behavioural and ECoG sleep after their microinfusion into the dorsal hippocampus. In addition, a dose (0.56 nmol) of clonidine which, given into the locus coeruleus, produced marked behavioural sleep and ECoG synchronization, lacked effects when given into the ventral or anterior thalamus, into the amygdaloid complex or onto the frontal and sensimotor cortex. The behavioural and ECoG spectrum power effects of clonidine given into the third cerebral ventricle or into the locus coeruleus were prevented by antagonists of alpha 2-adrenoceptors but not by alpha 1-adrenoceptor antagonists. Intraventricular microinjection, or microinfusion into the locus coeruleus, of yohimbine, a selective alpha 2-adrenoceptor antagonist, produced behavioural arousal, increase in locomotor and exploratory activity, tachypnoea and ECoG desynchronization with a significant reduction in total voltage power. Similar stimulatory effects were also observed after microinjection of phentolamine into the same sites. No significant effects on behaviour and ECoG activity were evoked after intraventricular injection or microinfusion into the locus coeruleus of prazosin or methoxamine. The behavioural and electrocortical (ECoG) effects of clonidine were studied after microinjection into the third cerebral ventricle, or microinfusion into some specific areas of the rat brain rich in noradrenaline‐containing cell bodies (locus coeruleus) or into areas receiving noradrenergic terminals (dorsal hippocampus, amygdaloid complex, thalamus, frontal and sensimotor cortex). The ECoG effects were continuously analysed and quantified by means of a Berg‐Fourier analyser as total power and as power in preselected bands of frequency. Clonidine (9.4 to 75 nmol) given into the third cerebral ventricle produced behavioural sedation and sleep and a dose‐dependent increase in ECoG total voltage power as well as in the lower frequency bands. Much lower doses were required to produce similar behavioural and ECoG spectrum power effects after either unilateral or bilateral microinfusion of clonidine into the locus coeruleus. Doses of clonidine equimolar to those given into the third cerebral ventricle, were almost ineffective in inducing behavioural and ECoG sleep after their microinfusion into the dorsal hippocampus. In addition, a dose (0.56 nmol) of clonidine which, given into the locus coeruleus, produced marked behavioural sleep and ECoG synchronization, lacked effects when given into the ventral or anterior thalamus, into the amygdaloid complex or onto the frontal and sensimotor cortex. The behavioural and ECoG spectrum power effects of clonidine given into the third cerebral ventricle or into the locus coeruleus were prevented by antagonists of α 2 ‐adrenoceptors but not by α 1 ‐adrenoceptor antagonists. Intraventricular microinjection, or microinfusion into the locus coeruleus, of yohimbine, a selective α 2 ‐adrenoceptor antagonist, produced behavioural arousal, increase in locomotor and exploratory activity, tachypnoea and ECoG desynchronization with a significant reduction in total voltage power. Similar stimulatory effects were also observed after microinjection of phentolamine into the same sites. No significant effects on behaviour and ECoG activity were evoked after intraventricular injection or microinfusion into the locus coeruleus of prazosin or methoxamine. |
Author | Ascioti, C De Sarro, G B Froio, F Nisticò, G Libri, V |
Author_xml | – sequence: 1 givenname: G B surname: De Sarro fullname: De Sarro, G B – sequence: 2 givenname: C surname: Ascioti fullname: Ascioti, C – sequence: 3 givenname: F surname: Froio fullname: Froio, F – sequence: 4 givenname: V surname: Libri fullname: Libri, V – sequence: 5 givenname: G surname: Nisticò fullname: Nisticò, G |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/2884006$$D View this record in MEDLINE/PubMed |
BookMark | eNpVUc1u1DAQtlBR2RYeAcniwC3B42TzwwEJVS0gVeICZ2viTDZeOfZiJ215Dx4Yp7tagS_2-PvxeL4rduG8I8begcghrQ_7HMq6yrZFAzm0TZ3PHYCUIn96wTZn6IJthBB1BtA0r9hVjHshElhvL9mlbJpSiGrD_tw-mJ6cJj6POHPr9RK59hQWS-lkYronHs1M_HGkQFxb70xvHHF0Pe_Dsosc9Wzcjic92sOIHLJn8FjIDPtAzms6zD4k8jCQnnm0RIcjLfglouUT6RGdiVN8zV4OaCO9Oe3X7Ofd7Y-br9n99y_fbj7fZ1pCVWZNWxB2ErEtJHTUQt_JriZI_lL2dVnJGgVudTWgHHrsmqEELNp-HY6shCyu2aej72HpJuo1uTmgVYdgJgy_lUej_kecGdXOPyhooZZQJoP3J4Pgfy0UZzWZqMladJQ-pdKwZQ2tSMSPR6IOPsZAw_kREGrNVO3VGpxae1NrpuqUqXpK4rf_tnmWnkIs_gKCOKRh |
CitedBy_id | crossref_primary_10_1097_00004703_200404000_00005 crossref_primary_10_1523_JNEUROSCI_16_21_06999_1996 crossref_primary_10_1111_j_1476_5381_1988_tb11715_x crossref_primary_10_1164_ajrccm_145_2_Pt_1_435 crossref_primary_10_1016_0024_3205_89_90528_6 crossref_primary_10_1007_s00213_005_0013_8 crossref_primary_10_1007_s12264_020_00625_0 crossref_primary_10_1034_j_1399_6576_2000_440604_x crossref_primary_10_1016_0028_3908_91_90124_T crossref_primary_10_1016_j_psym_2020_05_013 crossref_primary_10_1016_0006_8993_89_90315_6 crossref_primary_10_1016_j_brainres_2011_08_019 crossref_primary_10_1186_1753_4631_5_4 crossref_primary_10_1007_s00213_005_0171_8 crossref_primary_10_1021_jm001111b crossref_primary_10_1038_sj_bjp_0702016 crossref_primary_10_1016_S0306_4522_00_00047_6 crossref_primary_10_1016_S0006_8993_98_00266_2 crossref_primary_10_1097_00000539_199510000_00009 crossref_primary_10_1213_00000539_199801000_00039 crossref_primary_10_1016_j_neubiorev_2023_105311 crossref_primary_10_1046_j_1460_9592_1999_00379_x crossref_primary_10_1254_fpj_124_171 crossref_primary_10_1016_S0006_8993_97_00116_9 crossref_primary_10_1016_0091_3057_89_90060_9 crossref_primary_10_3109_07853899709002452 crossref_primary_10_1038_sj_npp_1301159 crossref_primary_10_1016_j_neuroscience_2010_06_009 crossref_primary_10_1186_s42077_022_00262_x crossref_primary_10_1016_j_ejphar_2016_10_009 crossref_primary_10_1016_0306_9877_92_90117_U crossref_primary_10_1007_BF00497780 crossref_primary_10_1007_BF02245339 crossref_primary_10_1016_j_neuroscience_2014_01_031 crossref_primary_10_1016_j_domaniend_2016_02_007 crossref_primary_10_1016_S0031_3955_05_70064_X crossref_primary_10_1016_j_egja_2012_08_001 crossref_primary_10_1016_S0024_3205_96_00692_3 crossref_primary_10_1177_0269881106071022 crossref_primary_10_3390_ijms24021477 crossref_primary_10_1007_BF00877082 crossref_primary_10_1038_sj_npp_1301145 crossref_primary_10_1111_j_1476_5381_1989_tb11784_x crossref_primary_10_1007_BF03013235 crossref_primary_10_1016_0361_9230_91_90225_9 crossref_primary_10_1016_0028_3908_88_90171_2 crossref_primary_10_1111_j_1530_0277_2009_01121_x crossref_primary_10_1016_0006_8993_91_90624_5 crossref_primary_10_1111_j_1399_6576_1993_tb03743_x crossref_primary_10_1016_S0014_2999_98_00296_9 crossref_primary_10_1016_S0306_4522_00_00215_3 crossref_primary_10_1111_j_1749_6632_1995_tb32388_x crossref_primary_10_1016_0014_2999_90_90591_S crossref_primary_10_1016_S0163_7258_01_00170_X crossref_primary_10_1016_S0306_4522_98_00306_6 crossref_primary_10_1213_00000539_199706000_00027 crossref_primary_10_1097_00000539_199706000_00027 crossref_primary_10_1590_S0100_879X2003000100012 crossref_primary_10_3109_00207459108985450 crossref_primary_10_1037_0735_7044_117_2_350 crossref_primary_10_1111_j_1600_0773_1991_tb01259_x crossref_primary_10_1111_j_2042_7158_1988_tb05252_x crossref_primary_10_1016_0169_328X_94_90386_7 crossref_primary_10_1016_S0197_0186_96_00039_3 crossref_primary_10_1016_j_neuropharm_2012_07_020 crossref_primary_10_1016_S0924_977X_00_00100_0 crossref_primary_10_1124_pr_117_014381 crossref_primary_10_1016_0024_3205_95_02158_F crossref_primary_10_3390_ani10061050 crossref_primary_10_1002_syn_20517 crossref_primary_10_1016_0301_0082_95_80007_U crossref_primary_10_1016_0361_9230_94_90051_5 crossref_primary_10_1016_j_brainresrev_2011_02_002 crossref_primary_10_1038_nn_2682 crossref_primary_10_1016_j_ejphar_2008_10_003 crossref_primary_10_1002_syn_20074 crossref_primary_10_1016_S0306_4522_99_00428_5 crossref_primary_10_1007_s11064_018_2533_8 crossref_primary_10_1097_PSY_0b013e31806d040b crossref_primary_10_1523_JNEUROSCI_16_21_07010_1996 crossref_primary_10_1111_j_1530_0277_2008_00860_x crossref_primary_10_1016_j_tvjl_2007_11_003 crossref_primary_10_1111_fcp_12648 crossref_primary_10_1007_s00213_013_3141_6 crossref_primary_10_1016_j_smrv_2022_101592 crossref_primary_10_1016_S0361_9230_99_00057_X crossref_primary_10_1016_0361_9230_94_00167_Y crossref_primary_10_1038_sj_npp_1301363 crossref_primary_10_1016_S0306_4522_03_00331_2 crossref_primary_10_1046_j_1446_9235_2003_00004_x crossref_primary_10_1016_0306_4522_93_90507_C crossref_primary_10_1177_026988119400800101 crossref_primary_10_1016_j_lfs_2019_01_009 crossref_primary_10_1097_00000539_199801000_00039 crossref_primary_10_2196_55129 crossref_primary_10_1016_0014_2999_91_90172_M crossref_primary_10_1111_j_1749_6632_1992_tb27455_x crossref_primary_10_1254_jjp_60_353 crossref_primary_10_1016_0306_3623_91_90008_T crossref_primary_10_1016_0014_2999_93_90856_D crossref_primary_10_1016_0002_9149_88_90461_4 crossref_primary_10_1016_j_euroneuro_2014_08_001 crossref_primary_10_1016_S0031_6989_88_80743_4 crossref_primary_10_1038_sj_bjp_0704237 crossref_primary_10_1007_s00210_020_01850_0 crossref_primary_10_1016_0006_3223_92_90217_N crossref_primary_10_1016_S0277_0326_96_80004_3 crossref_primary_10_1093_sleep_zsab017 crossref_primary_10_1073_pnas_1202526109 crossref_primary_10_1016_0006_8993_92_90508_7 crossref_primary_10_1016_0006_8993_94_91930_5 crossref_primary_10_1152_ajpregu_2001_281_6_R1868 crossref_primary_10_1007_s00213_004_2125_y crossref_primary_10_1016_0924_977X_94_90303_4 crossref_primary_10_1037_0735_7044_119_3_743 crossref_primary_10_1111_j_1460_9592_2011_03543_x crossref_primary_10_1111_j_1527_3458_2004_tb00008_x crossref_primary_10_1111_j_1476_5381_1990_tb14136_x crossref_primary_10_1213_00000539_199510000_00009 crossref_primary_10_1016_0014_2999_96_00194_X crossref_primary_10_1038_npp_2017_294 crossref_primary_10_1016_0028_3908_89_90200_1 crossref_primary_10_1016_0304_3959_94_90225_9 crossref_primary_10_1016_j_neuropharm_2020_108151 crossref_primary_10_1016_0306_3623_91_90468_L crossref_primary_10_1016_S1043_6618_89_80039_8 crossref_primary_10_1016_0166_2236_91_90086_A crossref_primary_10_1021_jm501456p crossref_primary_10_2504_kds_55_283 crossref_primary_10_1111_j_1755_5922_2011_00268_x crossref_primary_10_1515_REVNEURO_1993_4_1_63 crossref_primary_10_1016_0306_9877_95_90139_6 crossref_primary_10_1523_JNEUROSCI_1956_18_2018 crossref_primary_10_1016_0361_9230_91_90106_T crossref_primary_10_1111_j_1749_6632_1991_tb16974_x crossref_primary_10_1016_S0006_8993_99_02147_2 crossref_primary_10_1007_s10557_006_7653_8 crossref_primary_10_1016_j_pnpbp_2004_05_033 crossref_primary_10_1046_j_1439_0442_2001_00381_x crossref_primary_10_1186_s12576_021_00824_y crossref_primary_10_1016_j_neubiorev_2007_02_004 crossref_primary_10_1016_j_pneurobio_2006_08_001 crossref_primary_10_1038_sj_mp_4001351 crossref_primary_10_1016_0306_3623_94_90153_8 crossref_primary_10_1007_s00213_009_1537_0 crossref_primary_10_1016_j_brainres_2009_09_036 crossref_primary_10_1016_0301_0082_93_90018_N crossref_primary_10_1038_ajh_2012_93 crossref_primary_10_1016_S0031_6989_88_80074_2 crossref_primary_10_1046_j_1365_2885_1998_00113_x crossref_primary_10_1097_00005344_200000004_00005 crossref_primary_10_1016_0014_2999_92_90696_2 crossref_primary_10_1097_00005344_200000004_00004 crossref_primary_10_1111_j_1749_6632_1991_tb33868_x crossref_primary_10_1097_00000539_200204000_00016 crossref_primary_10_1046_j_1439_0442_2000_00254_x crossref_primary_10_1016_j_ejphar_2006_08_064 crossref_primary_10_1016_S0165_0173_03_00143_7 crossref_primary_10_1016_0361_9230_94_90174_0 crossref_primary_10_1016_S0091_3057_96_00118_9 crossref_primary_10_1111_j_1476_5381_1988_tb11765_x crossref_primary_10_1016_0024_3205_94_00319_X crossref_primary_10_1016_0028_3908_90_90057_X crossref_primary_10_1590_S0102_86502014000100007 crossref_primary_10_1016_0166_4328_95_00253_7 crossref_primary_10_1177_026988118700100201 crossref_primary_10_1053_bean_2000_0086 crossref_primary_10_1007_s00540_006_0426_5 crossref_primary_10_1016_j_brainresrev_2007_10_013 crossref_primary_10_1016_j_smrv_2011_12_003 crossref_primary_10_1111_j_1527_3466_1993_tb00198_x crossref_primary_10_1016_j_celrep_2018_08_046 crossref_primary_10_1093_sleep_33_12_1711 crossref_primary_10_1016_S0735_1097_99_00565_3 crossref_primary_10_1016_S0950_3501_95_80055_7 crossref_primary_10_1007_BF02244069 crossref_primary_10_1016_j_neuroimage_2009_02_045 crossref_primary_10_1177_1049909110389804 |
Cites_doi | 10.1111/j.1476-5381.1975.tb07421.x 10.1111/j.1476-5381.1981.tb16770.x 10.1016/0006-8993(75)90656-3 10.1016/0006-8993(76)91034-9 10.1111/j.1476-5381.1979.tb16116.x 10.1016/0006-8993(76)90498-4 10.1007/BF00423061 10.1002/cne.901810103 10.1126/science.1094539 10.1016/0014-2999(81)90426-X 10.1126/science.6278591 10.1007/BF00509764 10.1016/0006-8993(75)90276-0 10.1016/S0163-1047(79)90212-7 10.1016/0301-0082(77)90016-8 10.1016/0013-4694(82)90042-6 10.1016/0006-8993(74)90075-4 10.1007/BFb0034538 10.1111/j.1365-201X.1971.tb11000.x 10.1073/pnas.77.3.1696 10.1016/0006-2952(74)90187-7 10.1016/S0163-1047(79)90393-5 10.1007/978-1-4684-0101-1 10.1016/0301-0082(76)90013-7 10.1016/0013-4694(78)90005-6 10.1111/j.1476-5381.1976.tb08628.x 10.1523/JNEUROSCI.01-08-00876.1981 10.1016/S0031-6989(83)80053-8 10.1016/0022-3956(82)90001-2 10.1523/JNEUROSCI.01-08-00887.1981 10.1016/0024-3205(82)90656-7 10.1007/BF00572428 10.1016/0014-2999(71)90130-0 10.1007/BF01952538 10.1016/B978-0-12-547620-1.50007-2 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1111/j.1476-5381.1987.tb11220.x |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1476-5381 |
EndPage | 685 |
ExternalDocumentID | 10_1111_j_1476_5381_1987_tb11220_x 2884006 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .3N .55 .GJ 05W 0R~ 1OC 23N 24P 2WC 31~ 33P 36B 3O- 3SF 3V. 4.4 52U 52V 53G 5GY 6J9 7RV 7X7 8-0 8-1 88E 8AO 8FE 8FH 8FI 8FJ 8R4 8R5 8UM A00 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCUV ABDBF ABPVW ABQWH ABUWG ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACXBN ACXME ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFKRA AFPWT AFRAH AFZJQ AHBTC AHMBA AIACR AIAGR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB AOIJS ATUGU AZBYB AZVAB B0M BAFTC BAWUL BBNVY BENPR BFHJK BHBCM BHPHI BKEYQ BMXJE BPHCQ BRXPI BVXVI C45 CAG CCPQU CGR COF CS3 CUY CVF DCZOG DIK DRFUL DRMAN DRSTM DU5 E3Z EAD EAP EAS EBC EBD EBS ECM ECV EIF EJD EMB EMK EMOBN ENC ESX EX3 F5P FUBAC FYUFA G-S GODZA GX1 H.X HCIFZ HGLYW HMCUK HYE HZ~ J5H KBYEO LATKE LEEKS LH4 LITHE LK8 LOXES LSO LUTES LW6 LYRES M1P M7P MEWTI MK0 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ N9A NAPCQ NF~ NPM O66 O9- OIG OK1 OVD P2P P2W P4E PQQKQ PROAC PSQYO Q.N Q2X QB0 RIG ROL RPM RWI SJN SUPJJ SV3 TEORI TR2 TUS UKHRP UPT WBKPD WH7 WHWMO WIH WIJ WIK WIN WOHZO WOW WVDHM WXSBR X7M XV2 Y6R YHG ZA5 ZGI ZXP ZZTAW ~8M ~S- AAYXX AITYG ALIPV CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c2164-893eab2aa9321be91db2b7e1fec22d74627a0a5c6fa2fdab8f41a39d538126023 |
IEDL.DBID | RPM |
ISSN | 0007-1188 |
IngestDate | Tue Sep 17 21:16:23 EDT 2024 Sat Aug 17 01:38:09 EDT 2024 Fri Aug 23 03:42:36 EDT 2024 Thu May 23 23:50:36 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c2164-893eab2aa9321be91db2b7e1fec22d74627a0a5c6fa2fdab8f41a39d538126023 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 2884006 |
PQID | 77527190 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_1917214 proquest_miscellaneous_77527190 crossref_primary_10_1111_j_1476_5381_1987_tb11220_x pubmed_primary_2884006 |
PublicationCentury | 1900 |
PublicationDate | 1987-Apr 1987-04-00 19870401 |
PublicationDateYYYYMMDD | 1987-04-01 |
PublicationDate_xml | – month: 04 year: 1987 text: 1987-Apr |
PublicationDecade | 1980 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | British journal of pharmacology |
PublicationTitleAlternate | Br J Pharmacol |
PublicationYear | 1987 |
References | DEPOORTERE H. (e_1_2_1_16_1) 1981 MOORE K.Y. (e_1_2_1_27_1) 1984 e_1_2_1_41_1 e_1_2_1_24_1 e_1_2_1_45_1 e_1_2_1_22_1 e_1_2_1_43_1 e_1_2_1_26_1 e_1_2_1_47_1 DREW G.H. (e_1_2_1_18_1) 1979; 67 SAKAI K. (e_1_2_1_38_1) 1980 e_1_2_1_8_1 e_1_2_1_6_1 e_1_2_1_12_1 e_1_2_1_35_1 e_1_2_1_50_1 e_1_2_1_33_1 e_1_2_1_2_1 ASCIOTI C. (e_1_2_1_4_1) 1985 e_1_2_1_39_1 KOELLA W.P. (e_1_2_1_20_1) 1978 e_1_2_1_37_1 STARKE K. (e_1_2_1_42_1) 1979 DEPOORTERE H. (e_1_2_1_17_1) 1985 BRUNNER H. (e_1_2_1_9_1) 1968 MORONI F. (e_1_2_1_28_1) 1980; 20 MARLEY E. (e_1_2_1_25_1) 1972 e_1_2_1_40_1 e_1_2_1_23_1 e_1_2_1_46_1 e_1_2_1_21_1 e_1_2_1_44_1 e_1_2_1_48_1 ZWIETEN P.A. (e_1_2_1_49_1) 1975; 1 e_1_2_1_29_1 NISTICÒ G. (e_1_2_1_31_1) 1979; 4 CAVERO I. (e_1_2_1_10_1) 1978; 62 e_1_2_1_7_1 DAHLSTROM A. (e_1_2_1_14_1) 1964; 232 e_1_2_1_5_1 e_1_2_1_3_1 e_1_2_1_13_1 NISTICÒ G. (e_1_2_1_30_1) 1981; 6 e_1_2_1_34_1 e_1_2_1_51_1 e_1_2_1_11_1 e_1_2_1_32_1 e_1_2_1_15_1 e_1_2_1_36_1 e_1_2_1_19_1 |
References_xml | – start-page: 283 volume-title: Sleep 1980. 5th Eur. Congr. Sleep Res. Amsterdam 1980 year: 1981 ident: e_1_2_1_16_1 contributor: fullname: DEPOORTERE H. – ident: e_1_2_1_23_1 doi: 10.1111/j.1476-5381.1975.tb07421.x – ident: e_1_2_1_7_1 doi: 10.1111/j.1476-5381.1981.tb16770.x – volume: 232 start-page: 1 year: 1964 ident: e_1_2_1_14_1 article-title: Evidence for the existence of monoamine containing neurons in the central nervous system. I. Demonstration of monoamine in the cell bodies of brain stem neurons publication-title: Acta physiol. scand. contributor: fullname: DAHLSTROM A. – ident: e_1_2_1_33_1 doi: 10.1016/0006-8993(75)90656-3 – ident: e_1_2_1_46_1 doi: 10.1016/0006-8993(76)91034-9 – start-page: 676P issue: 86 year: 1985 ident: e_1_2_1_4_1 article-title: Locus coeruleus: site of sedation and sleep induced by clonidine publication-title: Br. J. Pharmac. Proc. contributor: fullname: ASCIOTI C. – volume: 67 start-page: 133 year: 1979 ident: e_1_2_1_18_1 article-title: α‐Adrenoceptors mediate clonidine‐induced sedation in the rat publication-title: Br. J. Pharmac. doi: 10.1111/j.1476-5381.1979.tb16116.x contributor: fullname: DREW G.H. – ident: e_1_2_1_36_1 doi: 10.1016/0006-8993(76)90498-4 – volume: 1 start-page: 1 year: 1975 ident: e_1_2_1_49_1 article-title: Antihypertensive drugs with a central action publication-title: Prog. Pharmac. contributor: fullname: ZWIETEN P.A. – ident: e_1_2_1_51_1 doi: 10.1007/BF00423061 – ident: e_1_2_1_29_1 doi: 10.1002/cne.901810103 – ident: e_1_2_1_19_1 doi: 10.1126/science.1094539 – ident: e_1_2_1_47_1 doi: 10.1016/0014-2999(81)90426-X – volume: 4 start-page: 115 year: 1979 ident: e_1_2_1_31_1 article-title: Profound behavioural and electrocortical sleep after intracerebroventricular infusion of guanabenz publication-title: Res. Comm. Chem. Psychol. Psychiat. Behavior contributor: fullname: NISTICÒ G. – ident: e_1_2_1_2_1 doi: 10.1126/science.6278591 – start-page: 79 volume-title: Sleep: Neurotransmitters and Neuromodulators year: 1985 ident: e_1_2_1_17_1 contributor: fullname: DEPOORTERE H. – ident: e_1_2_1_34_1 doi: 10.1007/BF00509764 – start-page: 1 volume-title: Presynaptic Receptors year: 1979 ident: e_1_2_1_42_1 contributor: fullname: STARKE K. – volume: 20 start-page: 272S year: 1980 ident: e_1_2_1_28_1 article-title: Intracerebroventricular noradrenaline or locus coeruleus stimulation increase the output of GABA and decrease that of Ach from guinea‐pig cerebral cortex publication-title: Neurosci. Lett. contributor: fullname: MORONI F. – volume: 6 start-page: 351 year: 1981 ident: e_1_2_1_30_1 article-title: Comparative effects of β‐endorphin and dermorphin on behaviour, electrocortical activity and spectrum power in chicks after intraventricular administration publication-title: Res. Commun. Psychol. Psychiat. Behavior contributor: fullname: NISTICÒ G. – ident: e_1_2_1_44_1 doi: 10.1016/0006-8993(75)90276-0 – ident: e_1_2_1_35_1 doi: 10.1016/S0163-1047(79)90212-7 – ident: e_1_2_1_3_1 doi: 10.1016/0301-0082(77)90016-8 – ident: e_1_2_1_11_1 doi: 10.1016/0013-4694(82)90042-6 – ident: e_1_2_1_12_1 doi: 10.1016/0006-8993(74)90075-4 – ident: e_1_2_1_41_1 doi: 10.1007/BFb0034538 – ident: e_1_2_1_48_1 doi: 10.1111/j.1365-201X.1971.tb11000.x – ident: e_1_2_1_50_1 doi: 10.1073/pnas.77.3.1696 – start-page: 180 volume-title: Hochdrucktherapie year: 1968 ident: e_1_2_1_9_1 contributor: fullname: BRUNNER H. – ident: e_1_2_1_22_1 doi: 10.1016/0006-2952(74)90187-7 – ident: e_1_2_1_13_1 doi: 10.1016/S0163-1047(79)90393-5 – ident: e_1_2_1_45_1 doi: 10.1007/978-1-4684-0101-1 – ident: e_1_2_1_43_1 doi: 10.1016/0301-0082(76)90013-7 – ident: e_1_2_1_8_1 doi: 10.1016/0013-4694(78)90005-6 – start-page: 427 volume-title: The Reticular System Revisited year: 1980 ident: e_1_2_1_38_1 contributor: fullname: SAKAI K. – ident: e_1_2_1_15_1 doi: 10.1111/j.1476-5381.1976.tb08628.x – start-page: 123 volume-title: Handbook of Chemical Neuroanatomy. Classical Transmitters in the CNS. Part. I year: 1984 ident: e_1_2_1_27_1 contributor: fullname: MOORE K.Y. – ident: e_1_2_1_6_1 doi: 10.1523/JNEUROSCI.01-08-00876.1981 – ident: e_1_2_1_24_1 doi: 10.1016/S0031-6989(83)80053-8 – ident: e_1_2_1_37_1 doi: 10.1016/0022-3956(82)90001-2 – ident: e_1_2_1_5_1 doi: 10.1523/JNEUROSCI.01-08-00887.1981 – start-page: 11 volume-title: A Therapeutic Approach to the Psyche Via Beta‐Adrenergic System year: 1978 ident: e_1_2_1_20_1 contributor: fullname: KOELLA W.P. – ident: e_1_2_1_26_1 doi: 10.1016/0024-3205(82)90656-7 – ident: e_1_2_1_40_1 doi: 10.1007/BF00572428 – ident: e_1_2_1_39_1 doi: 10.1016/0014-2999(71)90130-0 – volume: 62 start-page: 468 year: 1978 ident: e_1_2_1_10_1 article-title: The effects of prazosin on the clonidine induced hypotension and bradycardia in rats and sedation in chicks publication-title: Br. J. Pharmac. contributor: fullname: CAVERO I. – ident: e_1_2_1_21_1 doi: 10.1007/BF01952538 – ident: e_1_2_1_32_1 doi: 10.1016/B978-0-12-547620-1.50007-2 – start-page: 463 volume-title: Handbook of exp Pharmac year: 1972 ident: e_1_2_1_25_1 contributor: fullname: MARLEY E. |
SSID | ssj0014775 |
Score | 1.3513552 |
Snippet | The behavioural and electrocortical (ECoG) effects of clonidine were studied after microinjection into the third cerebral ventricle, or microinfusion into some... |
SourceID | pubmedcentral proquest crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 675 |
SubjectTerms | Adrenergic alpha-Antagonists - pharmacology Animals Arousal - drug effects Clonidine - pharmacology Electroencephalography Injections, Intraventricular Locus Coeruleus - drug effects Male Methoxamine - pharmacology Microinjections Phentolamine - pharmacology Prazosin - pharmacology Rats Rats, Inbred Strains Receptors, Adrenergic, alpha - drug effects Sleep - drug effects Yohimbine - pharmacology |
Title | Evidence that locus coeruleus is the site where clonidine and drugs acting at alpha 1- and alpha 2-adrenoceptors affect sleep and arousal mechanisms |
URI | https://www.ncbi.nlm.nih.gov/pubmed/2884006 https://search.proquest.com/docview/77527190 https://pubmed.ncbi.nlm.nih.gov/PMC1917214 |
Volume | 90 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDCaaAgN2GdZtxdK1HQ9DT3USybKVHIuiDxTokEML5GZIttwGSOzAD2z9H_vBI_1o0-3WgwHbkgnJJEESIj8C_JikMz0J0oShLwNPyUSRzqXKc75hOC5au-Fq5Nuf4fW9ulkEix0I-lqYJmk_tstRtlqPsuVjk1u5WcfjPk9sPL895xhDCjUewED7fh-id0cHSuu2bQGjH4rptEMa7dJ3lA490nEx4mB7VFlyN-SE0ajfySnFOtz4aNs-_ed0_ps7uWWMLj_Ch86LxLN2tXuw47JPcDJvYaifTvHupaqqPMUTnL8AVD99hj99K1GsHk2FZM7qEuPcFfXK0d2ypPcO-VgZfxEhh_GKNJ-MnEOTJZgU9UOJXBCRPSB935TrovCawfZBeoYrxHPOmckLmtxkjWC5cm7TTivyuqQdrB1XHi_LdfkF7i8v7s6vva47gxdLirE8cnScsdIY8gCFdTORWGm1E0RPykSrUGozMUEcpkamxPFpqoTxZwn_fQqipL8Pu1meua-Alry2kPgwM9YonRItEhepLV9hnMRD8HueRJsWhCPaDl50GDHViHkadTyNfg_he8--iHSGD0JM5mh3EUmI1OQJDWG_ZeYz1U4IhqBfcfl5nMG4X4-QjDag3J1MHrz5y2_wntffZgUdwm5V1O6IHJ7KHsPgaiGOGzH_C9cMAnU |
link.rule.ids | 230,315,733,786,790,891,27957,27958,53827,53829 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFH4aQwgujF8ThY35gHZa0sZ14vaIpk0F1qmHDu1m2YmzVbRJlR-C8XfwB_NenGzdOMEhUlLHT33y5_g9-XufAT4O0rEchGlC0pehJ3gicM6lwrNDTXJc-N81VSNPz6PJhfhyGV5uQdjVwjSk_dgs_Gy58rPFdcOtXK_ifscT68-mx5Rj8ED0H8FjnK9cdkl6u3kgpHQHF5D-YTAatVqjLYFHyMjDXoFP6bZfGQw4-ID0qJ_wEWY7dPTR5gr1V9j5kD25sRyd7sC3zhHHQvnu15Xx418PNB7_2dMX8LwNUNkn1_wStmz2Cg5nTuH65ojN7wq2yiN2yGZ32tc3r-F3d0opq651xXClrEsW57aolxbvFiX-bhntWLMfaMiyeIkfFVw_LdNZwpKivioZ1VpkVwz7N5XALPCaRvfAPU3F5znRcfICX24IKaxcWrt2rxV5XaIHK0tFzYtyVb6Bi9OT-fHEaw9-8GKO6ZuHMZTVhmuNwWVg7DhIDDfSBmiP80SKiEs90GEcpZqnCKZRKgI9HCc0rJif8eEubGd5Zt8CMxgQRjjAY220kCnaQiRyaeiK4iTuwbAbbLV2-h5qMy-SkSKrisCiWrConz046HChcDrSHovOLHqnEHpcYpDVg12HklurLbp6IO_B57addL7vtyAoGr3vFgTv_rvnATydzKdn6uzz-df38Ix8ceSjPdiuitruY1xVmQ_NLPoDnSUjdQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDCa2Dht22btY9qoOQ0-1EyuKFR-HbkH3aJFDCxS7CJIst0ETO_ADW_c79oNHWnabdrceDNiWRJjQJ4uEyI8AH0dZIkeTLCXqy0kgeCpwzWUicGNNdFz47ZqykQ-P4oMT8e10crpR6qsN2rdmEebLVZgvztvYyvXKDvs4seH8cJ98DB6J4TrNhvfhAa5ZnvSOeneAIKT0xQuIAzGaTju-0S6IR8g4wFFRSC53WBs0OviIOKkf8il6PFT-aHOX-s_0vB1BubElzZ7Cz14ZH4lyETa1Ce2fWzyPd9L2GTzpDFX2yXd5Dvdc_gJ2557p-nKPHV8nblV7bJfNrzmwL1_C375aKavPdc1wx2wqZgtXNkuHd4sK3ztGJ9fsFwpyzC7x54L7qGM6T1laNmcVo5yL_Izh-DYjmEVB2-gfeKApCb2gsJyixM5tYAqrls6tfbeyaCrUYOUouXlRrapXcDL7crx_EHQFIALL0Y0L0JZy2nCt0ciMjEui1HAjXYTyOE-liLnUIz2xcaZ5hqCaZiLS4ySlqUU_jY-3YSsvcvcamEHDMMZJTrTRQmYoCxHJpaErtqkdwLifcLX2PB9q0z-SsSKpigCjOsCo3wPY6bGhcFnSWYvOHWqnEH5corE1gG2PlCupHcIGIG9A6Kqd-L5vtiAwWt7vDghv7jxyBx7NP8_Uj69H39_CY1LFxyC9g626bNx7NK9q86FdSP8ApxIl9Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evidence+that+locus+coeruleus+is+the+site+where+clonidine+and+drugs+acting+at+alpha+1-+and+alpha+2-adrenoceptors+affect+sleep+and+arousal+mechanisms&rft.jtitle=British+journal+of+pharmacology&rft.au=De+Sarro%2C+G+B&rft.au=Ascioti%2C+C&rft.au=Froio%2C+F&rft.au=Libri%2C+V&rft.date=1987-04-01&rft.issn=0007-1188&rft.eissn=1476-5381&rft.volume=90&rft.issue=4&rft.spage=675&rft_id=info:doi/10.1111%2Fj.1476-5381.1987.tb11220.x&rft_id=info%3Apmid%2F2884006&rft.externalDocID=2884006 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1188&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1188&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1188&client=summon |